Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report)’s stock price was up 0.1% on Thursday . The stock traded as high as $39.25 and last traded at $39.25. Approximately 407 shares traded hands during mid-day trading, a decline of 74% from the average daily volume of 1,583 shares. The stock had previously closed at $39.20.
Hikma Pharmaceuticals Price Performance
The company’s 50 day moving average price is $36.77 and its two-hundred day moving average price is $39.43.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.
The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.
Recommended Stories
- Five stocks we like better than Hikma Pharmaceuticals
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
